Moderna's stock soars 8% after beating revenue, earnings expectations for the quarterMarket Watch • 05/04/22
Moderna sold $5.9 billion in Covid shots in the first quarter as it delivers better-than-expected earningsCNBC • 05/04/22
Moderna Reports First Quarter 2022 Financial Results and Provides Business UpdatesAccesswire • 05/04/22
Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: ReutersBenzinga • 05/02/22
FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUABenzinga • 04/29/22
Moderna files for authorization of its COVID-19 vaccine in young children in EuropeMarket Watch • 04/29/22
Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European UnionAccesswire • 04/29/22
FDA panel to discuss Novavax Covid vaccine for adults, Pfizer and Moderna shots for kids in JuneCNBC • 04/29/22